Lung, Phase II

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Volunteers
Health Professionals

What is the purpose of this trial?

This is a phase 2 study to investigate NC318 alone or in combination with Pembrolizumab in patients with advanced non-small cell lung cancer.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Elin Rowen

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Scott Gettinger, MD
Professor of Internal Medicine (Medical Oncology); Chief, Thoracic Medical Oncology

Sub-Investigators

Last Updated
12/22/2023
Study HIC
#2000028206